Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902823 · ClinicalTrials.gov registry record · Phase 2
Effect of Cancer Nurse Navigators on Patient Outcomes
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT01902823 is a Phase 2 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants.
The verdict
NCT01902823, a Phase 2 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
There is widespread anecdotal evidence that Cancer Nurse Navigators (CNNs) are highly valued by cancer patients, but no studies have evaluated the effects of CNNs on important patient-reported outcomes or indicators of quality of care. This study has two aims: 1. To assess the feasibility of studying the impact of Aurora CNN Program. 2. To pilot test the effects of CNN services on patient-reported outcomes and indicators of quality of care.
Interventions
- BEHAVIORAL Services from a Nurse Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01902823
The ClinicalTrials.gov registry entry for NCT01902823 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Services from a Nurse Navigator is the first listed.
NCT01902823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01902823 about?
NCT01902823 is a clinical study titled "Effect of Cancer Nurse Navigators on Patient Outcomes". There is widespread anecdotal evidence that Cancer Nurse Navigators (CNNs) are highly valued by cancer patients, but no studies have evaluated the effects of CNNs on important patient-reported outcomes or indicators of quality of care. This study has two aims: 1. To assess the feasibility of studyi...
What is the current status of trial NCT01902823?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2011-11. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01902823?
The interventions under investigation include: Services from a Nurse Navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT01902823?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.